The Effect of Short-term L-citrulline Supplementation on Blood Pressure and Arterial Stiffness
NCT ID: NCT05974813
Last Updated: 2023-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2023-01-01
2023-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Does L-citrulline favorably affect blood pressure at rest and during exercise?
* Does L-citrulline favorably affect arterial stiffness?
* Does L-citrulline favorably affect muscle oxygenation at rest and during exercise?
Participants will be asked to consume L-citrulline and a placebo for six days and participate in the evaluation of their blood pressure, arterial stiffness, and muscle oxygenation before and after each intervention.
Researchers will compare L-citrulline and placebo groups to examine whether L-citrulline supplementation affects the above health parameters.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
2 Weeks of Citrulline Supplementation on Arterial Function in Postmenopausal Women With Elevated Blood Pressure or Hypertension
NCT06025383
L-citrulline Supplementation & Cold Exposure
NCT01462591
Effects of L-Arginine and Citrulline Malate Supplementation on Sport Performance in Physically Active Men
NCT06938126
8 Weeks of L-CIT Supplementation and LIRET on Vascular Function in Hypertensive Postmenopausal Women
NCT05227781
Effects of L-arginine and L-citrulline Supplementation on Muscle Respiration
NCT03998800
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
L-Citrulline
Participants will receive 6 g (3 g every 12 h) of L-citrulline (Now, L-citrulline Pure Powder) for six-days.
L-Citrulline
6 g (3 g every 12 h) of L-citrulline for six days
Placebo
Participants will receive 6 g (3 g every 12 h) of maltodextrin (Now, Maltodextrin) for six-days.
Placebo
6 g (3 g every 12 h) of maltodextrin for six days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L-Citrulline
6 g (3 g every 12 h) of L-citrulline for six days
Placebo
6 g (3 g every 12 h) of maltodextrin for six days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal health profile.
Exclusion Criteria
* smoker.
* consumption of any medication the last three months.
* consumption of any nutritional supplement the last three months.
55 Years
70 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European University Cyprus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Anastasios Theodorou
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marios Vryonides, Dr.
Role: STUDY_DIRECTOR
European University Cyprus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
European University Cyprus
Nicosia, , Cyprus
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EUC_cit
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.